iHuman Inc. provides childhood edutainment products and services to individual users, education organizations, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Magic Math, iHuman Books, and iHuman Stories. It also provides learning materials in physical and digital formats; and learning devices. The company was founded in 1996 and is based in Beijing, the People's Republic of China.
IPO Year: 2020
Exchange: NYSE
Website: ihuman.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/30/2022 | $3.10 | Buy | Citigroup |
SC 13G/A - iHuman Inc. (0001814423) (Subject)
SC 13G/A - iHuman Inc. (0001814423) (Subject)
SC 13G - iHuman Inc. (0001814423) (Subject)
SC 13G - iHuman Inc. (0001814423) (Subject)
SC 13G - iHuman Inc. (0001814423) (Subject)
SCHEDULE 13G/A - iHuman Inc. (0001814423) (Subject)
SCHEDULE 13G/A - iHuman Inc. (0001814423) (Subject)
6-K - iHuman Inc. (0001814423) (Filer)
6-K - iHuman Inc. (0001814423) (Filer)
SCHEDULE 13G/A - iHuman Inc. (0001814423) (Subject)
20-F - iHuman Inc. (0001814423) (Filer)
6-K - iHuman Inc. (0001814423) (Filer)
SCHEDULE 13G/A - iHuman Inc. (0001814423) (Subject)
6-K - iHuman Inc. (0001814423) (Filer)
6-K - iHuman Inc. (0001814423) (Filer)
Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10
BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.Operating income was RMB18.8 million (US$2.6 million), compared wi
BEIJING, June 28, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Revenues were RMB235.0 million (US$32.5 million), compared with RMB265.2 million in the same period last year.Gross profit was RMB168.1 million (US$23.3 million), compared with RMB185.6 million in the same period last year.Operating income was RMB17.5 million (US$2.4 million), compared with
BEIJING, Feb. 29, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenues were RMB250.4 million (US$35.3 million), compared with RMB260.7 million in the same period last year.Gross profit was RMB178.2 million (US$25.1 million), compared with RMB181.0 million in the same period last year.Operating income was RMB21.9 million (US$3.1 mi
BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.Operating income was RMB18.8 million (US$2.6 million), compared wi
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, September 24 and Wednesday, September 25, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. Representatives from participating companies based in China, France, Hong Kong, Netherlands, Philippines, Portugal, Spain, Switzerland, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log i
BEIJING, June 28, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Revenues were RMB235.0 million (US$32.5 million), compared with RMB265.2 million in the same period last year.Gross profit was RMB168.1 million (US$23.3 million), compared with RMB185.6 million in the same period last year.Operating income was RMB17.5 million (US$2.4 million), compared with
BEIJING, April 25, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 25, 2024. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements for the year ended December 31, 2023, free of charge, to its shareholders and ADS holders upon request. Requests should be directed t
BEIJING, Feb. 29, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenues were RMB250.4 million (US$35.3 million), compared with RMB260.7 million in the same period last year.Gross profit was RMB178.2 million (US$25.1 million), compared with RMB181.0 million in the same period last year.Operating income was RMB21.9 million (US$3.1 mi
BEIJING, Dec. 28, 2023 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights Revenues were RMB261.5 million (US$35.8 million), compared with RMB251.5 million in the same period last year.Gross profit was RMB186.6 million (US$25.6 million), compared with RMB177.1 million in the same period last year.Operating income was RMB40.4 million (US$5.5 million), compared
BEIJING, Nov. 02, 2023 (GLOBE NEWSWIRE) -- iHuman Inc. (NYSE:IH), a leading provider of tech-powered, intellectual developments in China, today announced that its Investor Relations Director Justin Zhang will present at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on November 9. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors. DATE:November 9, 2023TIME:8:00 AM ETLINK: https://bit.ly/3rhvMzf This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the co
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Wednesday, November 8 and Thursday, November 9, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. Representatives from participating companies based in Australia, China, France, Germany, Greece, Hong Kong, Netherlands, Philippines and Taiwan will respond to questions during formal presentations and will also interact with investors via virtual trade booths. The conference is targeted to all categories of investors and analysts interested in non-US companies.
BEIJING, Sept. 21, 2023 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights Revenues were RMB241.0 million (US$33.2 million), compared with RMB230.6 million in the same period last year.Gross profit was RMB170.8 million (US$23.6 million), compared with RMB163.2 million in the same period last year.Operating income was RMB40.9 million (US$5.6 million), a year-over
BEIJING, Aug. 4, 2023 /PRNewswire/ -- Ms. Vivien Wang, Director and Chief Financial Officer (CFO) of iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, was recognized as "CFO of the Year 2022-2023" in the 2022-2023 Financial Performance Awards (the "Awards") presented by North American Business. This prestigious honor is a clear indication of how the capital markets recognize and value the exceptional leadership capabilities of iHuman's management team. Ms. Wang was recognized alongside other executives from respected companies including Zach Kirkhorn, CFO of Tesla; Brian Newman, CFO of UPS; and Nick Wang, CFO o
Key Takeaways: iHuman’s revenue and profit both declined in the first quarter as it accelerated a global expansion plan to diversify beyond its softening home market in China The company’s gross margin and total users both improved, but the omission of its latest paid user count suggests that key metric continued to decline By Doug Young Sometimes what’s left unsaid speaks the loudest. That could partly explain the 4.3% decline for shares of iHuman Inc. (NYSE:IH), a provider of educational products and services for young children, after it published its latest quarterly results last Friday. The report notably didn’t include the company’s latest number of paying users at the end of Ma
Gainers Hanryu Holdings (NASDAQ:HRYU) shares moved upwards by 21.6% to $0.61 during Monday's pre-market session. The market value of their outstanding shares is at $32.1 million. Leafly Holdings (NASDAQ:LFLY) stock increased by 16.02% to $2.72. The market value of their outstanding shares is at $6.2 million. Treasure Global (NASDAQ:TGL) shares rose 13.42% to $4.9. The market value of their outstanding shares is at $6.3 million. Collective Audience (NASDAQ:CAUD) shares rose 7.52% to $0.51. The market value of their outstanding shares is at $7.0 million. TruGolf Holdings (NASDAQ:TRUG) shares increased by 5.71% to $1.85. The market value of their outstanding shares is at $24.5 million. Tu
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. • NB Bancorp (NASDAQ:NBBK) is likely to report earnings for its Fiscal Year 2023. • Verona Pharma (NASDAQ:VRNA) is projected to report quarterly loss at $0.26 per share on revenue of $0. • iHuman (NYSE:IH) is estimated to report earnings for its fourth quarter. • argenx (NASDAQ:ARGX) is estimated to report quarterly loss at $1.71 per share on revenue of $364.75 million. • Titan Intl (NYSE:TWI) is expected to report quarterly earnings at $0.28 per share on revenue of $413.57 million. • Canadian Imperial Bank (NYSE:CM) is projected to repo
iHuman (NYSE:IH) reported quarterly adjsuted earnings of $0.09 per share. This is a 18.18 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $35.27 million in sales this quarter. This is a 6.68 percent decrease over sales of $37.80 million the same period last year.
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. Below is a list of notable value stocks in the consumer defensive sector: Adecoagro (NYSE:AGRO) - P/E: 7.15 Archer-Daniels Midland (NYSE:ADM) - P/E: 7.33 iHuman (NYSE:IH) - P/E: 4.84 Bunge Global (NYSE:BG) - P/E: 6.7 Seneca Foods (NASDAQ:SENEB) - P/E: 6.68 Adecoagro has reported Q3 earnings per share at $0.83, which has increased by 107.5% compared to Q2, which was 0.4. Its most recent dividend yield is at 3.9
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. Below is a list of notable value stocks in the consumer defensive sector: Perdoceo Education (NASDAQ:PRDO) - P/E: 8.15 iHuman (NYSE:IH) - P/E: 6.25 S&W Seed (NASDAQ:SANW) - P/E: 1.82 Seneca Foods (NASDAQ:SENEB) - P/E: 6.75 Albertsons Companies (NYSE:ACI) - P/E: 9.34 This qu
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. Below is a list of notable value stocks in the consumer defensive sector: Sunlands Technology (NYSE:STG) - P/E: 1.48 Perdoceo Education (NASDAQ:PRDO) - P/E: 8.24 Bunge Global (NYSE:BG) - P/E: 7.87 iHuman (NYSE:IH) - P/E: 6.57 Adecoagro (NYSE:AGRO) - P/E: 8.09 Sunlands Technology's earnings per share for Q3 sits at $1.31, whereas in Q2, they were at 1.73. Perdoceo Education's earnings per share for Q3 sits at $
Average total MAUs for the quarter were 25.36 million, an increase of 22.9% year-over-year from 20.63 million in the same period last year. The number of paying users was 1.54 million.
iHuman (NYSE:IH) reported quarterly earnings of $0.14 per share. This is a 27.27 percent increase over earnings of $0.11 per share from the same period last year. The company reported $35.80 million in sales this quarter. This is a 1.25 percent increase over sales of $35.36 million the same period last year.